{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:24:02Z","timestamp":1778628242136,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ejso.2005.09.011","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:52:41Z","timestamp":1131007961000},"page":"39-43","source":"Crossref","is-referenced-by-count":51,"title":["Positron emission tomography in patients with breast cancer using 18F-3\u2032-deoxy-3\u2032-fluoro-l-thymidine (18F-FLT)\u2014a pilot study"],"prefix":"10.1016","volume":"32","author":[{"given":"L.B.","family":"Been","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.","family":"Elsinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.P.","family":"Cobben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.L.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.H.","family":"Suurmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ejso.2005.09.011_bib1","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","article-title":"Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations","volume":"18","author":"Avril","year":"2000","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2005.09.011_bib2","first-page":"1186","article-title":"Breast imaging with fluorine-18-FDG PET: quantitative image analysis","volume":"38","author":"Avril","year":"1997","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.ejso.2005.09.011_bib3","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s002590050319","article-title":"Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and P53 in primary breast cancer: a preliminary observation","volume":"25","author":"Crippa","year":"1998","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"10.1016\/j.ejso.2005.09.011_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.187.3.8497624","article-title":"Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-d-glucose PET","volume":"187","author":"Adler","year":"1993","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.ejso.2005.09.011_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00006231-200209000-00009","article-title":"Comparison of fluorodeoxyglucose positron emission tomography and \u2018conventional diagnostic procedures\u2019 for the detection of distant metastases in breast cancer patients","volume":"23","author":"Dose","year":"2002","journal-title":"Nucl Med Commun"},{"issue":"10","key":"10.1016\/j.ejso.2005.09.011_bib6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","article-title":"FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters","volume":"29","author":"Buck","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.ejso.2005.09.011_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.2004.07.058","article-title":"18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer","volume":"22","author":"van der Hoeven","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2005.09.011_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0001-2998(99)80029-4","article-title":"18-FDG imaging in breast cancer","volume":"29","author":"Hoh","year":"1999","journal-title":"Semin Nucl Med"},{"issue":"11","key":"10.1016\/j.ejso.2005.09.011_bib9","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ejso.2005.09.011_bib10","first-page":"1210","article-title":"Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells","volume":"43","author":"Rasey","year":"2002","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.ejso.2005.09.011_bib11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-003-1257-3","article-title":"[(18)F]FLT PET for diagnosis and staging of thoracic tumours","volume":"30","author":"Dittmann","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.ejso.2005.09.011_bib12","first-page":"3315","article-title":"In vivo validation of 3\u2032deoxy-3\u2032-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with ki-67 immunohistochemistry and flow cytometry in human lung tumors","volume":"8","author":"Vesselle","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.ejso.2005.09.011_bib13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s00259-003-1187-0","article-title":"Potential impact of [18F]3\u2032-deoxy-3\u2032-fluorothymidine versus [18F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer","volume":"30","author":"Francis","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.ejso.2005.09.011_bib14","first-page":"1426","article-title":"Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG","volume":"44","author":"Buck","year":"2003","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.ejso.2005.09.011_bib15","first-page":"1927","article-title":"3\u2032-(18)F-fluoro-3\u2032-deoxy-l-thymidine: a new tracer for staging metastatic melanoma?","volume":"44","author":"Cobben","year":"2003","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.ejso.2005.09.011_bib16","first-page":"226","article-title":"18F-FLT PET for visualization of laryngeal cancer: comparison with (18)F-FDG PET","volume":"45","author":"Cobben","year":"2004","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.ejso.2005.09.011_bib17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/1078-0432.CCR-03-0040","article-title":"Detection and grading of soft tissue sarcomas of the extremities with (18)F-3\u2032-fluoro-3\u2032-deoxy-l-thymidine","volume":"10","author":"Cobben","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ejso.2005.09.011_bib18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/infdis\/170.6.1394","article-title":"Relationship between plasma concentrations of 3\u2032-deoxy-3\u2032-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials","volume":"170","author":"Flexner","year":"1994","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ejso.2005.09.011_bib19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1023\/A:1010684101509","article-title":"Simplified labeling approach for synthesizing 3\u2032-deoxy-3\u2032-[18F]fluorothymidine ([18F]FLT)","volume":"243","author":"Machulla","year":"2000","journal-title":"J Radioanalytical Nucl Chem"},{"issue":"9","key":"10.1016\/j.ejso.2005.09.011_bib20","first-page":"1482","article-title":"18F-fluorothymidine radiation dosimetry in human pet imaging studies","volume":"44","author":"Vesselle","year":"2003","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.ejso.2005.09.011_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s002590050426","article-title":"Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction","volume":"26","author":"Lonneux","year":"1999","journal-title":"Eur J Nucl Med"},{"issue":"12","key":"10.1016\/j.ejso.2005.09.011_bib22","first-page":"3331","article-title":"3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules","volume":"62","author":"Buck","year":"2002","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ejso.2005.09.011_bib23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00259-004-1462-8","article-title":"PET with [(18)F]fluorothymidine for imaging of primary breast cancer: a pilot study","volume":"31","author":"Smyczek-Gargya","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.ejso.2005.09.011_bib24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00259-004-1687-6","article-title":"[18F]FLT-PET in oncology; current status and opportunities","volume":"31","author":"Been","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2005.09.011_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-004-1532-y","article-title":"Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations","author":"Krak","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.ejso.2005.09.011_bib26","first-page":"695","article-title":"Selectivity of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine (FLT) and 2-[18F]fluoro-2-deoxy-d-glucose (FDG) for tumor versus inflammation in a rodent model","volume":"45","author":"Van Waarde","year":"2004","journal-title":"J Nucl Med"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798305002581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798305002581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:50:27Z","timestamp":1554339027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798305002581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0748798305002581"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2005.09.011","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}